↓ Skip to main content

Intermittent Explosive Disorder

Overview of attention for article published in CNS Drugs, August 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

blogs
1 blog
twitter
2 X users

Citations

dimensions_citation
95 Dimensions

Readers on

mendeley
51 Mendeley
Title
Intermittent Explosive Disorder
Published in
CNS Drugs, August 2012
DOI 10.2165/00023210-200216080-00002
Pubmed ID
Authors

Rene L. Olvera

Timeline
X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 51 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Norway 1 2%
Unknown 50 98%

Demographic breakdown

Readers by professional status Count As %
Other 7 14%
Researcher 7 14%
Student > Bachelor 5 10%
Student > Doctoral Student 5 10%
Student > Ph. D. Student 5 10%
Other 9 18%
Unknown 13 25%
Readers by discipline Count As %
Psychology 15 29%
Medicine and Dentistry 12 24%
Nursing and Health Professions 3 6%
Neuroscience 2 4%
Agricultural and Biological Sciences 1 2%
Other 5 10%
Unknown 13 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 January 2022.
All research outputs
#4,572,012
of 26,571,961 outputs
Outputs from CNS Drugs
#426
of 1,427 outputs
Outputs of similar age
#31,325
of 190,008 outputs
Outputs of similar age from CNS Drugs
#139
of 549 outputs
Altmetric has tracked 26,571,961 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,427 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.2. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 190,008 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 549 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.